智通財經APP獲悉,香港聯交所最新資料顯示,6月21日,CEO楊建新增持基石藥業(02616)16.05萬股,平均每股作價爲1.0912港元,總金額約17.52萬港元。增持後最新持股數目約爲6893.73萬股,持股比例爲5.37%。
補充資料:Box 28: Such shares represent the restricted shares units and share options granted and to be issued to Dr. Yang pursuant to the Pre-IPO RSU Scheme, Pre-IPO Share Option Scheme and Post-IPO Incentive Schemes.Total of 3,237, 580 restricted shares units granted to Dr. Yang on January 16, 2019 were all vested by February 16, 2023.